Intraoperative anesthetic management in patients with pulmonary hypertension;Intraoperatives anästhesiologisches management bei patienten mit pulmonaler hypertonie

Intensiv- und Notfallbehandlung

Volumn 29, Issue 1, 2004, Pages 4-13

  Rinne, T ^a   Zwissler, B ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Anesthesia; Complications; Management; Pulmonary hypertension

Indexed keywords

ADRENALIN; ANESTHETIC AGENT; ATRACURIUM; DESFLURANE; HALOTHANE; ILOPROST; ISOFLURANE; MILRINONE; MIVACURIUM; NITROUS OXIDE; NORADRENALIN; PROSTACYCLIN;

ANESTHESIA; ARTERY CATHETERIZATION; ELECTROCARDIOGRAM; EMBOLISM; EPIDURAL ANESTHESIA; HUMAN; INHALATION ANESTHESIA; INTRAVENOUS ANESTHESIA; LUNG FUNCTION TEST; MORTALITY; PATHOPHYSIOLOGY; PATIENT MONITORING; PEROPERATIVE COMPLICATION; PREMEDICATION; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; SPINAL ANESTHESIA; THORAX RADIOGRAPHY; THROMBOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 2342572768     PISSN: 09475362     EISSN: None     Source Type: Journal    
DOI: 10.5414/ibp29004     Document Type: Review

References (47)

1. Benotti J.R., J.E. Dalen: The natural history of pulmonary embolism. Clin. Chest Med. 5, 403-410 (1984).
2. Biondi J.W., D.S. Schulman, R. Soufer et al.: The effect of incremental positive end-expiratory pressure on right ventricular hemodynamics and ejection fraction. Anesth. Analg. 67, 144-151 (1988).
3. Blaise G., D. Langleben, B. Huber: Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology 99, 1415-1432 (2003).
4. Christman B.W., C.D. McPherson, J.H. Newman, GA. King, G.R. Bernard, B.M. Groves, J.E. Loyd: An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N. Engl. J. Med. 327, 70-75 (1992).
5. Fischer L.G., H. Van Aken, H. Bürkle: Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesth. Analg. 96, 1603-1616 (2003).
6. Giaid A., D. Saleh: Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 333, 214-221 (1995).
7. 2) in healthy lambs: effects on tracheal, bronchial and alveolar morphologhy. Intens. Care Med. 22, 1232-1238 (1996).
8. 2) for 8 hours does not produce signs of acute pulmonary toxicity in healthy lambs. Intens. Care Med. 22, 426-433 (1996).
9. Hachenberg T., D. Holst, C. Ebel et al.: Effect of thoracic epidural anesthesia on ventilation-perfusion distribution and intrathoracic blood volume before and after induction of general anesthesia. Acta Anaesthesiol. Scand. 41, 1142-1148 (1997).
10. Haraldsson A., N. Kieler-Jensen, S.E. Ricksten: The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension. Anesth. Analg. 93, 1439-1445 (2001).
11. Hebb C.: Motor innervation of the pulmonary blood vessels of mammals. In: Fishman AP, H.H. Hecht: The Pulmonary Circulation and Interstitial Space. University of Chicago Press, Chicago 1969, 195-217.
12. Hickey P.R., D.D. Hansen, M. Strafford, J.E. Thompson, R.E. Jonas, J.E. Mayer: Pulmonary and systemic hemodynamic effects of nitrous oxide in infants with normal and elevated pulmonary vascular resistance. Anesthesiology 65, 374-378 (1986).
13. Hickey P.R., D.D. Hansen, G. M. Cramolini et al.: Pulmonary and systemic hemodynamic response to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology 62, 287-293 (1985).
14. Jardin F., J.C. Farcot, L. Boisante et al.: Influence of positive end-expiratory pressure on left ventricular performance. N. Engl. J. Med. 304, 387-392 (1981).
15. Jenkins J., A. Lynn, J. Edmonds, G. Barker: Effects of mechanical ventilation on cardiopulmonary function in children after open-heart surgery. Crit. Care Med. 13, 77-80 (1985).
16. Kadosaki M., T. Kawamura, K. Oyama, N. Nara, J. Wei, N. Mori: Usefulnes of nitric oxide treatment for pulmonary hypertension in infants during cardiac anesthesia. Anesthesiology 96, 835-840 (2002).
17. Kubota N., Y. Morimoto, O. Kemmotsu: Anesthetic management for cesarian section in a patient with mitral stenosis and severe pulmonary hypertension. Masui 52, 177-179 (2003).
18. Louie E.K., S. Rich, B.H. Brundage: Doppler echocardiography assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to primary pulmonary hypertension. J. Am. Coll. Cardiol. 8, 1298-1306 (1986).
19. Lynch C.: Are volatile anesthetics really calcium entry blockers? Anesthesiology 61, 644-646 (1984).
20. Marcus J.T., N.A. Vonk, R.J. Roeleveld, P.E. Postmus, R.M. Heethaar, A.C. Van Rossum, A. Boonstra: Impaired left ventricular filling due to right ventricular pressure overload in primary pulmonary hypertension: Noninvasive monitoring using MRI. Chest 119, 1761-1765 (2001).
21. McIntyre K.M., A.A. Sasahara: The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am. J. Cardiol. 28, 288-294 (1971).
22. Medical Research Council Working Party: Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema: report of the Medical Research Council Working Party. Lancet I, 681-686 (1981).
23. Naeije R.: Should pulmonary hypertension be treated in chronic obstructive pulmonary disease? In: Weir E.K., S.I. Archer, J.T. Reeves: The Diagnosis and Treatment of Pulmonary Hypertension. Futura Publishing, Mount Kisco 1992, 209-239.
24. Nakayama M., U. Kondo, P.A. Murray: Pulmonary vasodilator response to adenosine triphosphate-sensitive potassium channel activation is attenuated during desflurane but preserved during sevoflurane anesthesia compared with the conscious state. Anesthesiology 88, 1023-1035 (1998).
25. Pagel P.S., J.L. Fu, M.C. Damask, R.F. Davis, P.N. Samuelson, M.B. Howie, D.C. Warltier: Desflurane and isoflurane produce similar alterations in systemic and pulmonary hemodynamics and arterial oxygenation in patients undergoing one-lung ventilation during thoracotomy. Anesth. Analg. 87, 800-807 (1998).
26. Pollard J.B.: Common mechanisms and strategies for prevention and treatment of cardiac arrest during epidural anesthesia. J. Clin. Anesth. 14, 52-56 (2002).
27. Presberg K.W., H.E. Dincer: Pathophysiology of pulmonary hypertension due to lung disease. Curr. Opin. Pulm. Med. 9, 131-138 (2003).
28. Ricciardi M.J., M. Rubenfire: How to manage secondary pulmonary hypertension. Postgrad. Med. 105, 183-190 (1999).
29. Rich S., D.R. Dantzker, S.M. Ayres et al.: Primary pulmonary hypertension: a national prospective study. Ann. Intern. Med. 107, 216-223 (1987).
30. Rich S., E. Kaufmann, P.S. Levy: The effect of high-doses of calcium channel blockers on survival in primary pulmonary hypertension. N. Engl. J. Med. 327, 76-81 (1992).
31. Roques F., S.A. Nashef, P. Michel, E. Gauducheau, C. de Vincentiis, E. Baudet, J. Cortina, M. David, A. Faichney, F. Gabrielle, E. Gams, A. Harjula, M.T. Jones, P.P. Pintor, R. Salamon, L. Thulin: Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19,030 patients. Eur. J. Cardiothorac. Surg. 15, 816-823 (1999).
32. Schulte-Sasse U., W. Hess, J. Tarnow: Pulmonary vascular responses to nitrous oxide in patients with normal and high pulmonary vascular resistance. Anesthesiology 57, 9-13 (1982).
33. Seki S., K. Sato, M. Nakayama, P.A. Murray: Halothane and enflurane attenuate pulmonary vasodilation mediated by adenosine triphosphate-sensitive potassium channels compared to the conscious state. Anesthesiology 86, 923-935 (1997).
34. Solina A.R., S.H. Ginsberg, D. Papp, E.J. Pantin, J. Denny, I. Ghandivel, T.J. Krause: Response to nitric oxide during adult cardiac surgery. J. Invest. Surg. 15, 5-14 (2002).
35. Strange J.W., J. Wharton, P.G. Phillips, M.R. Wilkins: Recent insights into the pathogenesis and therapeutics of pulmonary hypertension. Clin. Sci. (Lond.) 102, 253-268 (2002).
36. Sykes M.K., J.B. Hurtig, A.R. Tait, M.K. Chakrabarti: Reduction of hypoxic pulmonary vasoconstriction in the dog during administration of nitrous oxide. Br. J. Anaesth. 49, 301-307 (1977).
37. Tempe D., J.C. Mohan, A. Cooper et al.: Myocardial depressant effect of nitrous oxide after valve surgery. Anesthesiology 14, 672 (1997).
38. Troncy E., M. Francoeur, I. Salazkin, F. Yang, M. Charbonneau, G. Leclerc, P. Vinay, G. Blaise: Extrapulmonary effects of inhaled nitric oxide in swine with and without phenylephrine. Br. J. Anaesth. 79, 631-640 (1997).
39. Veering B.T., M.J. Cousins: Cardiovascular and pulmonary effects of epidural anaesthesia. Anaesth. Intens. Care 28, 620-635 (2000).
40. Viitanen A., M. Salmenperä, J. Heinonen: Right ventricular response to hypercarbia after cardiac surgery. Anesthesiology 73, 393-400 (1990).
41. Von Dossow V., M. Welte, U. Zaune et al.: Thoracic epidural anesthesia combined with general anesthesia: the preferred anesthetic technique for thoracic surgery. Anesth. Analg. 92, 848-854 (2001).
42. Weiss B.M., M. Maggiorini, R. Jenni, U. Lauper, V. Popov, T. Bombelli, D.R. Spahn: Pregnant patient with primary pulmonary hypertension: inhaled pulmonary vasodilators and epidural anesthesia for cesarean section. Anesthesiology 92, 1191-1194 (2000).
43. Weitzenblum E., A. Sautegeau, M. Ehrhart et al.: Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 130, 993-998 (1984).
44. Wiedemann K., C. Diestelhorst: The effect of sedation on pulmonary function. Anästhesist 44, 588-593 (1995).
45. Zwissler B.: Das akute Rechtsherzversagen. Ätiologie - Pathophysiologie - Diagnostik - Therapie. Anästhesist 49, 788-808 (2000).
46. Zwissler B.: Inhalierte Vasodilatatoren. Anästhesist 51, 603-622 (2002).
47. 2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154, 1671-1677 (1996).